Breaking News

BioVaxys and BioElpida agree to begin ovarian cancer vaccine bioproduction

The two companies have signed the new definitive agreement focusing on the GMP facility build-out in Lyon, and ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...

Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

Manufacturing injectable devices: why modern means modular

If steadily emerging trends in the parenteral pharmaceutical landscape have taught us anything, it’s this: one ...

NerPharMa and ICROM partner on highly potent drugs and ADC-payloads

This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies

Catalent and Stirling Ultracold partner on energy-efficient cold chains

The company has agreed to use Stirling's ULT freezers that use 100% natural refrigerants and around 30% of the carbon ...

Real world evidence: helping to end COVID-19 disruption

Truly bringing the COVID-19 pandemic under control will take concerted efforts beyond the rollout of a global mass ...

Thermo Fisher launches first cleanroom-compatible CO2 incubator for cell culture

Thermo Fisher has designed the cell growth incubator with in-chamber HEPA filtration, on-demand 180°C sterilisation ...

AMRI expands capabilities across several sites

The expansion includes additional suites in New York, designed to manufacture batch sizes of 10-15 kilograms

Bispecific antibodies: an exciting new class of emerging therapeutics

Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...

Manufacturing Chemist Live: A hybrid event

Taking place on 14-15 September, the event will put delegates ahead of the curve in the global pharmaceutical supply ...

Transforming the downstream pharmaceutical landscape with data science

Overlooking the vast amount of available data that’s generated during downstream processing may be a significant ...

Lonza to double drug substance production for Moderna vaccine

In May 2020, the companies announced a 10-year agreement to enable the manufacture of the COVID-19 vaccine and ...

Vetter and Rentschler strengthen strategic alliance

The collaboration was initiated in 2020 with the intent to enable clients to bring their products to patients easier ...

Inspiration and Learning

People

Reports